Literature DB >> 27212868

Optimizing Urine Processing Protocols for Protein and Metabolite Detection.

Nazema Y Siddiqui1, Laura G DuBois2, Lisa St John-Williams2, Thompson J Will2, Carole Grenier3, Emily Burke4, Matthew O Fraser5, Cindy L Amundsen1, Susan K Murphy3.   

Abstract

BACKGROUND: In urine, factors such as timing of voids, and duration at room temperature (RT) may affect the quality of recovered protein and metabolite data. Additives may aid with detection, but can add more complexity in sample collection or analysis. We aimed to identify the optimal urine processing protocol for clinically-obtained urine samples that allows for the highest protein and metabolite yields with minimal degradation.
METHODS: Healthy women provided multiple urine samples during the same day. Women collected their first morning (1st AM) void and another "random void". Random voids were aliquotted with: 1) no additive; 2) boric acid (BA); 3) protease inhibitor (PI); or 4) both BA + PI. Of these aliquots, some were immediately stored at 4°C, and some were left at RT for 4 hours. Proteins and individual metabolites were quantified, normalized to creatinine concentrations, and compared across processing conditions. Sample pools corresponding to each processing condition were analyzed using mass spectrometry to assess protein degradation.
RESULTS: Ten Caucasian women between 35-65 years of age provided paired 1st morning and random voided urine samples. Normalized protein concentrations were slightly higher in 1st AM compared to random "spot" voids. The addition of BA did not significantly change proteins, while PI significantly improved normalized protein concentrations, regardless of whether samples were immediately cooled or left at RT for 4 hours. In pooled samples, there were minimal differences in protein degradation under the various conditions we tested. In metabolite analyses, there were significant differences in individual amino acids based on the timing of the void.
CONCLUSIONS: For comparative translational research using urine, information about void timing should be collected and standardized. For urine samples processed in the same day, BA does not appear to be necessary while the addition of PI enhances protein yields, regardless of 4°C or RT storage temperature.

Entities:  

Keywords:  Boric acid; First morning void; Metabolomics; Protease inhibitors; Proteomics; Random void; Urine; Urine protein degradation

Year:  2015        PMID: 27212868      PMCID: PMC4872872     

Source DB:  PubMed          Journal:  J Proteomics Bioinform        ISSN: 0974-276X


  17 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.

Authors:  Stefan Schaub; John Wilkins; Tracey Weiler; Kevin Sangster; David Rush; Peter Nickerson
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

3.  Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability.

Authors:  Visith Thongboonkerd; Somchai Chutipongtanate; Rattiyaporn Kanlaya
Journal:  J Proteome Res       Date:  2006-01       Impact factor: 4.466

Review 4.  Urine collection and processing for protein biomarker discovery and quantification.

Authors:  C Eric Thomas; Wade Sexton; Kaaron Benson; Rebecca Sutphen; John Koomen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

Review 5.  Practical points in urinary proteomics.

Authors:  Visith Thongboonkerd
Journal:  J Proteome Res       Date:  2007-09-07       Impact factor: 4.466

Review 6.  Urine in clinical proteomics.

Authors:  Stéphane Decramer; Anne Gonzalez de Peredo; Benjamin Breuil; Harald Mischak; Bernard Monsarrat; Jean-Loup Bascands; Joost P Schanstra
Journal:  Mol Cell Proteomics       Date:  2008-07-30       Impact factor: 5.911

7.  Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis.

Authors:  Dan Theodorescu; Stefan Wittke; Mark M Ross; Michael Walden; Mark Conaway; Ingo Just; Harald Mischak; Henry F Frierson
Journal:  Lancet Oncol       Date:  2006-03       Impact factor: 41.316

8.  Policy: NIH plans to enhance reproducibility.

Authors:  Francis S Collins; Lawrence A Tabak
Journal:  Nature       Date:  2014-01-30       Impact factor: 49.962

Review 9.  Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review.

Authors:  Abdul-Hamid Emwas; Claudio Luchinat; Paola Turano; Leonardo Tenori; Raja Roy; Reza M Salek; Danielle Ryan; Jasmeen S Merzaban; Rima Kaddurah-Daouk; Ana Carolina Zeri; G A Nagana Gowda; Daniel Raftery; Yulan Wang; Lorraine Brennan; David S Wishart
Journal:  Metabolomics       Date:  2014-11-21       Impact factor: 4.290

10.  An analysis of the impact of pre-analytical factors on the urine proteome: Sample processing time, temperature, and proteolysis.

Authors:  Sophie Hepburn; David A Cairns; David Jackson; Rachel A Craven; Beverley Riley; Michelle Hutchinson; Steven Wood; Matthew Welberry Smith; Douglas Thompson; Rosamonde E Banks
Journal:  Proteomics Clin Appl       Date:  2015-02-26       Impact factor: 3.494

View more
  1 in total

1.  Presence of Tumor Necrosis Factor-Alpha in Urine Samples of Patients With Chronic Low Back Pain Undergoing Chiropractic Care: Preliminary Findings From a Prospective Cohort Study.

Authors:  Carlos Gevers-Montoro; Mar Romero-Santiago; Lisa Losapio; Francisco Miguel Conesa-Buendía; Dave Newell; Luis Álvarez-Galovich; Mathieu Piché; Arantxa Ortega-De Mues
Journal:  Front Integr Neurosci       Date:  2022-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.